South Africa's government has estimated that universities and science councils could lose about $107 million in U.S. research ...

Just before a major HIV vaccine trial was to begin, U.S. funding cuts halted South Africa’s BRILLIANT project, threatening ...

In an interview with The News & Observer, Dr. Barton Haynes talks future of HIV vaccine development after HHS canceled the ...

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

The withdrawal of U.S. funding under the Trump administration has halted key HIV vaccine trials in South Africa, part of a ...

The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But ...

A new report by the U.N. AIDS agency says the sudden withdrawal of U.S. funding has caused a “systemic shock” to the global ...

The drug, in June, received FDA approval as the first twice-yearly pre-exposure prophylaxis (PrEP) option to reduce the risk ...

Known as the President's Emergency Plan for Aids Relief (Pepfar), it led to the investment of more than $100bn (£74bn) in the ...

Just a week before clinical trials were set to begin, South African scientists working on a promising HIV vaccine were told to halt all work, as the Trump administration abruptly withdrew $46 million ...

NEARLY 35 U.S. STATES are grappling with outbreaks of vaccine-preventable diseases like measles and whooping cough. A recent American Community Media ...

How will the Trump administration's cuts to HIV research impact the progress that's been made towards ending the epidemic in the U.S.?